呼吸促迫症候群の世界市場2019

GlobalInfoResearchが発行した調査報告書（GIR9103706）

◆英語タイトル：Global Respiratory Distress Syndrome Market 2019 by Company, Regions, Type and Application, Forecast to 2024
◆商品コード：GIR9103706
◆発行会社（リサーチ会社）：GlobalInfoResearch
◆発行日：2019年9月（※2024年版があります。お問い合わせください）
◆ページ数：102
◆レポート形式：英語 / PDF
◆納品方法：Eメール
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥515,040	見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）	USD5,220 ⇒換算￥772,560	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,030,080	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは、呼吸促迫症候群の世界市場について調べ、まとめました。種類別セグメントは、多孔剤アルファ、ベラクタント、カルファクタント、その他等、用途別セグメントは、非常に早産児、中期から後期の早産児、その他等に区分しました。呼吸促迫症候群の世界市場概観、企業動向、企業別呼吸促迫症候群シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・呼吸促迫症候群の市場概観
・呼吸促迫症候群の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・呼吸促迫症候群の企業別販売動向、市場シェア、市場集中度、競争動向
・呼吸促迫症候群の世界市場規模
・呼吸促迫症候群の北米市場分析（アメリカ、カナダ、メキシコ等）
・呼吸促迫症候群のアメリカ市場規模推移
・呼吸促迫症候群のカナダ市場規模推移
・呼吸促迫症候群のメキシコ市場規模推移
・呼吸促迫症候群のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・呼吸促迫症候群のドイツ市場規模推移
・呼吸促迫症候群のイギリス市場規模推移
・呼吸促迫症候群のロシア市場規模推移
・呼吸促迫症候群のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・呼吸促迫症候群の日本市場規模推移
・呼吸促迫症候群の中国市場規模推移
・呼吸促迫症候群の韓国市場規模推移
・呼吸促迫症候群のインド市場規模推移
・呼吸促迫症候群の東南アジア市場規模推移
・呼吸促迫症候群の南米市場分析（ブラジル、アルゼンチン等）
・呼吸促迫症候群の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・呼吸促迫症候群の種類別分析/販売量、売上、市場シェア（多孔剤アルファ、ベラクタント、カルファクタント、その他）
・呼吸促迫症候群の用途別分析/市場規模（非常に早産児、中期から後期の早産児、その他）
・呼吸促迫症候群の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・呼吸促迫症候群の販売チャネル・代理店・貿易業者・ディーラー分析

【レポートの概要】

Description

Scope of the Report:
The global Respiratory Distress Syndrome market is valued at 360.1 million USD in 2018 and is expected to reach 442.6 million USD by the end of 2024, growing at a CAGR of 5.3% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Respiratory Distress Syndrome.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Respiratory Distress Syndrome market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Respiratory Distress Syndrome market by product type and applications/end industries.

Market Segment by Companies, this report covers
Chiesi Farmaceutici
Market Breakdown by Regions
AbbVie
CR-Double Crane
Noargen
ONY Biotech
Europe
JW Pharmaceuticals
Yuhan Corporation
North America
China
Korea
RoW

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Poractant Alfa
Beractant
Calfactant
Others

Poractant Alpha’s largest market share is broken down to 67%.

Market Segment by Applications, can be divided into
Very Preterm Infants
Moderate to Late Preterm Infants
Others

Very Preterm shapes the largest segment of the application market

【レポートの目次】

Table of Contents

1 Respiratory Distress Syndrome Market Overview
1.1 Product Overview and Scope of Respiratory Distress Syndrome
1.2 Classification of Respiratory Distress Syndrome by Types
1.2.1 Global Respiratory Distress Syndrome Revenue Comparison by Types (2019-2024)
1.2.2 Global Respiratory Distress Syndrome Revenue Market Share by Types in 2018
1.2.3 Poractant Alfa
1.2.4 Beractant
1.2.5 Calfactant
1.2.6 Others
1.3 Global Respiratory Distress Syndrome Market by Application
1.3.1 Global Respiratory Distress Syndrome Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Very Preterm Infants
1.3.3 Moderate to Late Preterm Infants
1.3.4 Others
1.4 Global Respiratory Distress Syndrome Market by Regions
1.4.1 Global Respiratory Distress Syndrome Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Respiratory Distress Syndrome Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Respiratory Distress Syndrome Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Respiratory Distress Syndrome Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Respiratory Distress Syndrome Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Respiratory Distress Syndrome Status and Prospect (2014-2024)
1.5 Global Market Size of Respiratory Distress Syndrome (2014-2024)
2 Company Profiles
2.1 Chiesi Farmaceutici
2.1.1 Business Overview
2.1.2 Respiratory Distress Syndrome Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Chiesi Farmaceutici Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)
2.2 Market Breakdown by Regions
2.2.1 Business Overview
2.2.2 Respiratory Distress Syndrome Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Market Breakdown by Regions Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)
2.3 AbbVie
2.3.1 Business Overview
2.3.2 Respiratory Distress Syndrome Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 AbbVie Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)
2.4 CR-Double Crane
2.4.1 Business Overview
2.4.2 Respiratory Distress Syndrome Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 CR-Double Crane Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)
2.5 Noargen
2.5.1 Business Overview
2.5.2 Respiratory Distress Syndrome Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Noargen Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)
2.6 ONY Biotech
2.6.1 Business Overview
2.6.2 Respiratory Distress Syndrome Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 ONY Biotech Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)
2.7 Europe
2.7.1 Business Overview
2.7.2 Respiratory Distress Syndrome Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Europe Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)
2.8 JW Pharmaceuticals
2.8.1 Business Overview
2.8.2 Respiratory Distress Syndrome Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 JW Pharmaceuticals Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)
2.9 Yuhan Corporation
2.9.1 Business Overview
2.9.2 Respiratory Distress Syndrome Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Yuhan Corporation Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)
2.10 North America
2.10.1 Business Overview
2.10.2 Respiratory Distress Syndrome Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 North America Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)
2.11 China
2.11.1 Business Overview
2.11.2 Respiratory Distress Syndrome Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 China Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)
2.12 Korea
2.12.1 Business Overview
2.12.2 Respiratory Distress Syndrome Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Korea Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)
2.13 RoW
2.13.1 Business Overview
2.13.2 Respiratory Distress Syndrome Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 RoW Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)
3 Global Respiratory Distress Syndrome Market Competition, by Players
3.1 Global Respiratory Distress Syndrome Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Respiratory Distress Syndrome Players Market Share
3.2.2 Top 10 Respiratory Distress Syndrome Players Market Share
3.3 Market Competition Trend
4 Global Respiratory Distress Syndrome Market Size by Regions
4.1 Global Respiratory Distress Syndrome Revenue and Market Share by Regions
4.2 North America Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
4.3 Europe Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
4.5 South America Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
5 North America Respiratory Distress Syndrome Revenue by Countries
5.1 North America Respiratory Distress Syndrome Revenue by Countries (2014-2019)
5.2 USA Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
5.3 Canada Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
5.4 Mexico Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
6 Europe Respiratory Distress Syndrome Revenue by Countries
6.1 Europe Respiratory Distress Syndrome Revenue by Countries (2014-2019)
6.2 Germany Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
6.3 UK Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
6.4 France Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
6.5 Russia Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
6.6 Italy Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Respiratory Distress Syndrome Revenue by Countries
7.1 Asia-Pacific Respiratory Distress Syndrome Revenue by Countries (2014-2019)
7.2 China Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
7.3 Japan Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
7.4 Korea Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
7.5 India Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
8 South America Respiratory Distress Syndrome Revenue by Countries
8.1 South America Respiratory Distress Syndrome Revenue by Countries (2014-2019)
8.2 Brazil Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
8.3 Argentina Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
8.4 Colombia Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Respiratory Distress Syndrome by Countries
9.1 Middle East and Africa Respiratory Distress Syndrome Revenue by Countries (2014-2019)
9.2 Saudi Arabia Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
9.3 UAE Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
9.4 Egypt Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
9.5 Nigeria Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
9.6 South Africa Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
10 Global Respiratory Distress Syndrome Market Segment by Type
10.1 Global Respiratory Distress Syndrome Revenue and Market Share by Type (2014-2019)
10.2 Global Respiratory Distress Syndrome Market Forecast by Type (2019-2024)
10.3 Poractant Alfa Revenue Growth Rate (2014-2024)
10.4 Beractant Revenue Growth Rate (2014-2024)
10.5 Calfactant Revenue Growth Rate (2014-2024)
10.6 Others Revenue Growth Rate (2014-2024)
11 Global Respiratory Distress Syndrome Market Segment by Application
11.1 Global Respiratory Distress Syndrome Revenue Market Share by Application (2014-2019)
11.2 Respiratory Distress Syndrome Market Forecast by Application (2019-2024)
11.3 Very Preterm Infants Revenue Growth (2014-2019)
11.4 Moderate to Late Preterm Infants Revenue Growth (2014-2019)
11.5 Others Revenue Growth (2014-2019)
12 Global Respiratory Distress Syndrome Market Size Forecast (2019-2024)
12.1 Global Respiratory Distress Syndrome Market Size Forecast (2019-2024)
12.2 Global Respiratory Distress Syndrome Market Forecast by Regions (2019-2024)
12.3 North America Respiratory Distress Syndrome Revenue Market Forecast (2019-2024)
12.4 Europe Respiratory Distress Syndrome Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Respiratory Distress Syndrome Revenue Market Forecast (2019-2024)
12.6 South America Respiratory Distress Syndrome Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Respiratory Distress Syndrome Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Respiratory Distress Syndrome Picture
Table Product Specifications of Respiratory Distress Syndrome
Table Global Respiratory Distress Syndrome and Revenue (Million USD) Market Split by Product Type
Figure Global Respiratory Distress Syndrome Revenue Market Share by Types in 2018
Figure Poractant Alfa Picture
Figure Beractant Picture
Figure Calfactant Picture
Figure Others Picture
Table Global Respiratory Distress Syndrome Revenue (Million USD) by Application (2014-2024)
Figure Respiratory Distress Syndrome Revenue Market Share by Applications in 2018
Figure Very Preterm Infants Picture
Figure Moderate to Late Preterm Infants Picture
Figure Others Picture
Table Global Market Respiratory Distress Syndrome Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Respiratory Distress Syndrome Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Respiratory Distress Syndrome Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Respiratory Distress Syndrome Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Respiratory Distress Syndrome Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Respiratory Distress Syndrome Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Respiratory Distress Syndrome Revenue (Million USD) and Growth Rate (2014-2024)
Table Chiesi Farmaceutici Basic Information, Manufacturing Base and Competitors
Table Chiesi Farmaceutici Respiratory Distress Syndrome Type and Applications
Table Chiesi Farmaceutici Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)
Table Market Breakdown by Regions Basic Information, Manufacturing Base and Competitors
Table Market Breakdown by Regions Respiratory Distress Syndrome Type and Applications
Table Market Breakdown by Regions Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie Respiratory Distress Syndrome Type and Applications
Table AbbVie Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)
Table CR-Double Crane Basic Information, Manufacturing Base and Competitors
Table CR-Double Crane Respiratory Distress Syndrome Type and Applications
Table CR-Double Crane Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)
Table Noargen Basic Information, Manufacturing Base and Competitors
Table Noargen Respiratory Distress Syndrome Type and Applications
Table Noargen Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)
Table ONY Biotech Basic Information, Manufacturing Base and Competitors
Table ONY Biotech Respiratory Distress Syndrome Type and Applications
Table ONY Biotech Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)
Table Europe Basic Information, Manufacturing Base and Competitors
Table Europe Respiratory Distress Syndrome Type and Applications
Table Europe Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)
Table JW Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table JW Pharmaceuticals Respiratory Distress Syndrome Type and Applications
Table JW Pharmaceuticals Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)
Table Yuhan Corporation Basic Information, Manufacturing Base and Competitors
Table Yuhan Corporation Respiratory Distress Syndrome Type and Applications
Table Yuhan Corporation Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)
Table North America Basic Information, Manufacturing Base and Competitors
Table North America Respiratory Distress Syndrome Type and Applications
Table North America Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)
Table China Basic Information, Manufacturing Base and Competitors
Table China Respiratory Distress Syndrome Type and Applications
Table China Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)
Table Korea Basic Information, Manufacturing Base and Competitors
Table Korea Respiratory Distress Syndrome Type and Applications
Table Korea Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)
Table RoW Basic Information, Manufacturing Base and Competitors
Table RoW Respiratory Distress Syndrome Type and Applications
Table RoW Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2017-2018)
Table Global Respiratory Distress Syndrome Revenue (Million USD) by Players (2014-2019)
Table Global Respiratory Distress Syndrome Revenue Share by Players (2014-2019)
Figure Global Respiratory Distress Syndrome Revenue Share by Players in 2017
Figure Global Respiratory Distress Syndrome Revenue Share by Players in 2018
Figure Global Top 5 Players Respiratory Distress Syndrome Revenue Market Share in 2018
Figure Global Top 10 Players Respiratory Distress Syndrome Revenue Market Share in 2018
Figure Global Respiratory Distress Syndrome Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Respiratory Distress Syndrome Revenue (Million USD) by Regions (2014-2019)
Table Global Respiratory Distress Syndrome Revenue Market Share by Regions (2014-2019)
Figure Global Respiratory Distress Syndrome Revenue Market Share by Regions (2014-2019)
Figure Global Respiratory Distress Syndrome Revenue Market Share by Regions in 2018
Figure North America Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
Figure Europe Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
Figure South America Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
Table North America Respiratory Distress Syndrome Revenue by Countries (2014-2019)
Table North America Respiratory Distress Syndrome Revenue Market Share by Countries (2014-2019)
Figure North America Respiratory Distress Syndrome Revenue Market Share by Countries (2014-2019)
Figure North America Respiratory Distress Syndrome Revenue Market Share by Countries in 2018
Figure USA Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
Figure Canada Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
Figure Mexico Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
Table Europe Respiratory Distress Syndrome Revenue (Million USD) by Countries (2014-2019)
Figure Europe Respiratory Distress Syndrome Revenue Market Share by Countries (2014-2019)
Figure Europe Respiratory Distress Syndrome Revenue Market Share by Countries in 2018
Figure Germany Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
Figure UK Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
Figure France Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
Figure Russia Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
Figure Italy Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Respiratory Distress Syndrome Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Respiratory Distress Syndrome Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Respiratory Distress Syndrome Revenue Market Share by Countries in 2018
Figure China Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
Figure Japan Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
Figure Korea Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
Figure India Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
Table South America Respiratory Distress Syndrome Revenue by Countries (2014-2019)
Table South America Respiratory Distress Syndrome Revenue Market Share by Countries (2014-2019)
Figure South America Respiratory Distress Syndrome Revenue Market Share by Countries (2014-2019)
Figure South America Respiratory Distress Syndrome Revenue Market Share by Countries in 2018
Figure Brazil Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
Figure Argentina Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
Figure Colombia Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Respiratory Distress Syndrome Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Respiratory Distress Syndrome Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Respiratory Distress Syndrome Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Respiratory Distress Syndrome Revenue Market Share by Countries in 2018
Figure Saudi Arabia Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
Figure UAE Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
Figure Egypt Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
Figure Nigeria Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
Figure South Africa Respiratory Distress Syndrome Revenue and Growth Rate (2014-2019)
Table Global Respiratory Distress Syndrome Revenue (Million USD) by Type (2014-2019)
Table Global Respiratory Distress Syndrome Revenue Share by Type (2014-2019)
Figure Global Respiratory Distress Syndrome Revenue Share by Type (2014-2019)
Figure Global Respiratory Distress Syndrome Revenue Share by Type in 2018
Table Global Respiratory Distress Syndrome Revenue Forecast by Type (2019-2024)
Figure Global Respiratory Distress Syndrome Market Share Forecast by Type (2019-2024)
Figure Global Poractant Alfa Revenue Growth Rate (2014-2019)
Figure Global Beractant Revenue Growth Rate (2014-2019)
Figure Global Calfactant Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Table Global Respiratory Distress Syndrome Revenue by Application (2014-2019)
Table Global Respiratory Distress Syndrome Revenue Share by Application (2014-2019)
Figure Global Respiratory Distress Syndrome Revenue Share by Application (2014-2019)
Figure Global Respiratory Distress Syndrome Revenue Share by Application in 2018
Table Global Respiratory Distress Syndrome Revenue Forecast by Application (2019-2024)
Figure Global Respiratory Distress Syndrome Market Share Forecast by Application (2019-2024)
Figure Global Very Preterm Infants Revenue Growth Rate (2014-2019)
Figure Global Moderate to Late Preterm Infants Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Respiratory Distress Syndrome Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Respiratory Distress Syndrome Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Respiratory Distress Syndrome Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Respiratory Distress Syndrome Revenue Market Forecast (2019-2024)
Figure Europe Respiratory Distress Syndrome Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Respiratory Distress Syndrome Revenue Market Forecast (2019-2024)
Figure South America Respiratory Distress Syndrome Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Respiratory Distress Syndrome Revenue Market Forecast (2019-2024)

【掲載企業】

Chiesi Farmaceutici、 Market Breakdown by Regions、 AbbVie、 CR-Double Crane、 Noargen、 ONY Biotech、 Europe、 JW Pharmaceuticals、 Yuhan Corporation、 North America、 China、 Korea、 RoW、

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 呼吸促迫症候群の世界市場2019(Global Respiratory Distress Syndrome Market 2019 by Company, Regions, Type and Application, Forecast to 2024)]についてメールでお問い合わせはこちらでお願いします。

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 GlobalResearch.jp